Theranostics Finances and Coding of Today and a Look Forward

Area of Science:

• Nuclear Medicine
• Radiopharmaceutical Therapy
• Theranostics

Background:

• Theranostics is rapidly expanding, with more radiopharmaceutical therapies and clinical demand.
• Financial viability is essential for supporting these growing clinical programs.

Purpose of the Study:

• To provide a comprehensive overview of financial strategies for clinical theranostics programs in the US.
• To guide professionals in building financially sustainable theranostics services.

Main Methods:

• Review of Current Procedural Terminology and Healthcare Common Procedure Coding System coding.
• Analysis of reimbursement strategies, stakeholder engagement, and compliance.
• Exploration of dosimetry, amino acid infusion, and 340B pricing.

Main Results:

• Accurate coding, billing accuracy, and infrastructure investment are critical.
• Tools and resources exist to support operational success.
• A 5-year budget projection is necessary for scaling programs.

Conclusions:

• Financial planning is key to supporting the growth of theranostics.
• Sustainable programs require attention to coding, reimbursement, and infrastructure.
• This guidance equips professionals to meet future demand for theranostics.